FLNA
Price
$1.15
Change
-$0.03 (-2.54%)
Updated
Jul 13 closing price
Capitalization
56.04M
22 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$3.30
Change
-$0.26 (-7.30%)
Updated
Jul 13 closing price
Capitalization
1.75B
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FLNA vs RXRX

FLNA vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
FLNA vs. RXRX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLNA is a Buy and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (FLNA: $1.15 vs. RXRX: $3.30)
Brand notoriety: FLNA and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FLNA: 48% vs. RXRX: 94%
Market capitalization -- FLNA: $56.04M vs. RXRX: $1.75B
FLNA [@Biotechnology] is valued at $56.04M. RXRX’s [@Biotechnology] market capitalization is $1.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FLNA’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • FLNA’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than FLNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FLNA’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 3 bullish TA indicator(s).

  • FLNA’s TA Score: 3 bullish, 4 bearish.
  • RXRX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, FLNA is a better buy in the short-term than RXRX.

Price Growth

FLNA (@Biotechnology) experienced а -8.00% price change this week, while RXRX (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

FLNA is expected to report earnings on Aug 05, 2026.

RXRX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.75B) has a higher market cap than FLNA($56M). RXRX YTD gains are higher at: -19.315 vs. FLNA (-41.919). FLNA has higher annual earnings (EBITDA): -81.75M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. FLNA (86.6M). RXRX has higher revenues than FLNA: RXRX (65.7M) vs FLNA (0).
FLNARXRXFLNA / RXRX
Capitalization56M1.75B3%
EBITDA-81.75M-478.66M17%
Gain YTD-41.919-19.315217%
P/E RatioN/AN/A-
Revenue065.7M-
Total Cash86.6M654M13%
Total DebtN/A72.4M-
FUNDAMENTALS RATINGS
FLNA: Fundamental Ratings
FLNA
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FLNARXRX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 22 days ago
81%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
FLNA
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MBSF25.720.02
+0.08%
Regan Floating Rate MBS ETF
RFFC75.18N/A
N/A
ALPS Active Equity Opportunity ETF
WMSB24.99-0.06
-0.22%
Weitz Multisector Bond ETF
NVII24.35-0.70
-2.79%
REX NVDA Growth & Income ETF
FLKR55.21-4.83
-8.04%
Franklin FTSE South Korea ETF

FLNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, FLNA has been loosely correlated with RXRX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FLNA jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLNA
1D Price
Change %
FLNA100%
-2.54%
RXRX - FLNA
43%
Loosely correlated
-7.30%
EDIT - FLNA
41%
Loosely correlated
-3.07%
PRME - FLNA
39%
Loosely correlated
-7.01%
CRBU - FLNA
39%
Loosely correlated
-6.49%
ALT - FLNA
38%
Loosely correlated
-1.97%
More